Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4973 total record number 1 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 228 out of 498
4973 citations found

Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitis

Ingwersen, J;De Santi, L;Wingerath, B;Graf, J;Koop, B;Schneider, R;Hecker, C;Schrter, F;Bayer, M;Engelke, AD;Dietrich, M;Albrecht, P;Hartung, HP;Annunziata, P;Aktas, O;Prozorovski, T;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Postnatal refinement of interareal feedforward projections in ferret visual cortex

Khalil, R;Contreras-Ramirez, V;Levitt, JB;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

[18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis

Hoehne, A;James, ML;Alam, IS;Ronald, JA;Schneider, B;D'Souza, A;Witney, TH;Andrews, LE;Cropper, HC;Behera, D;Gowrishankar, G;Ding, Z;Wyss-Coray, T;Chin, FT;Biswal, S;Gambhir, SS;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas

Muangnil, P;Satitsri, S;Tadpetch, K;Saparpakorn, P;Chatsudthipong, V;Hannongbua, S;Rukachaisirikul, V;Muanprasat, C;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Top Down Tandem Mass Spectrometric Analysis of a Chemically Modified Rough-Type Lipopolysaccharide Vaccine Candidate

Oyler, BL;Khan, MM;Smith, DF;Harberts, EM;Kilgour, DPA;Ernst, RK;Cross, AS;Goodlett, DR;

Product: LPS from Escherichia coli J5 (Rc)

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

  • Materials and Methods

    Anthrax lethal factor (Product #172), and the chicken IgY polyclonal anti-LF antibody (Product # 769A) are
    products of List Biological Laboratories, Inc. The Nunc-Immuno Tubes, Maxisorp (cat# 444202) used for LF
    antibody coating and the dimethyl sulfoxide (DMSO) (cat # TS-20684) were purchased from ThermoScientific.
    The 96-well, black, flat bottom, non binding plates used for the fluorescent plate assay were from Corning
    (cat # 3991). Bovine plasma (cat # 7310806) was purchased from Lampire Biological Laboratories.

    Sample Preparation: Stock solutions of the fluorogenic substrates, MAPKKide® Plus (± biotin), were made
    2.5 mM in DMSO based on the peptide content determined by elemental analysis. The substrates were diluted
    in assay buffer: 20 mM HEPES, pH 8.0 containing 0.1% Tween-20. The LF was added to neat bovine plasma.

    LF Activity Assays:
    Antibody Capture: The Nunc-Immuno Maxisorp Tubes were coated with 1 mL of a 10 μg/ml solution of
    a chicken affinity purified polyclonal IgY antibody to anthrax lethal factor (List Prod # 769A).
    The immuno-tubes were incubated with the IgY overnight at 2-8°C. After 5 washes with 1.5 mL each of PBS containing 0.05%
    TWEEN-20 (PBST), the anti-LF coated tubes were exposed to 1 mL of a series of LF concentrations in neat
    plasma. The tubes were incubated at 22°C for 1 hour. Tubes were then washed 3 times with 1.5 ml PBST and
    1.0 ml of 10 μM MAPKKide® Plus (± biotin) was added. The reaction was allowed to proceed for 3, 5 and
    22 hours at 37°C. At each time point 250 μl of the reaction mixture was removed from triplicate tubes and placed
    in a 96 -well black plate. In the case of the biotinylated MAPKKide® Plus a 0.5 ml aliquot of each triplicate
    was added to streptavidin-coated beads after 22 hours of exposure to LF. The mixture was gently rotated at
    ambient room temperature for 1 hour and then read in the platereader.

    Prodcut #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis
    Product #769B – Anti-Lethal Factor from B. anthracis (Chicken lgY)
    Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor

Galectin-9 is Critical for Mucosal Adaptive Immunity through the TH17-IgA Axis

Liang, CC;Li, CS;Weng, IC;Chen, HY;Lu, HH;Huang, CC;Liu, FT;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization

Weng, Q;Wang, J;Wang, J;Wang, J;Sattar, F;Zhang, Z;Zheng, J;Xu, Z;Zhao, M;Liu, X;Yang, L;Hao, G;Fang, L;Lu, QR;Yang, B;He, Q;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt’s lymphoma cells

Debernardi, J;Hollville, E;Lipinski, M;Wiels, J;Robert, A;

Product: Shiga Toxin 1 from Escherichia coli

  • Reagents:

    Purified recombinant verotoxin-1 (VT-1) was purchased from List Biological Laboratories, Inc.

    Intracellular immunofluorescence:

    BAK and BAX conformational changes were tested by flow cytometry using conformational antibodies. Cells, treated or not with VT-1 for 6h, …